Medical News Today: What to know about nitroglycerin
Nitroglycerin is a drug that primarily treats a specific chest pain that doctors call angina. Learn about when they prescribe it, how it works to relieve angina, safe dosages, risks, and side effects here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2019 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news
BP Lowering on Way to Hospital a Fail in Acute Stroke (CME/CE)
(MedPage Today) -- Ambulance-based RIGHT-2 trial shows no benefit from nitroglycerin patch to treat elevated blood pressure (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 13, 2019 Category: Cardiology Source Type: news
RIGHT-2: No Benefit of Prehospital Nitroglycerin Patch in Stroke RIGHT-2: No Benefit of Prehospital Nitroglycerin Patch in Stroke
The neutral results in ischemic stroke and TIA are disappointing after earlier positive data, and suggestions of a positive and negative effect of nitroglycerin further complicate the interpretation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news
BP Lowering en Route to Hospital Flops in Acute Stroke
(MedPage Today) -- RIGHT-2 trial shows no benefit, possible harm from nitroglycerin patch (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 7, 2019 Category: Cardiology Source Type: news
Ambulance nitroglycerin patch to lower blood pressure did not improve stroke outcomes
(American Heart Association) Despite the promise of earlier small studies, a patch to lower stroke patient's blood pressure before reaching the hospital didn't improve stroke outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news
Not Just Acid Reflux: The Need to Think Worst First
Discussion
Heart disease is the leading cause of death in the United States.1 This year, 720,000 Americans will have a new coronary event—defined as first hospitalized myocardial infarction (MI) or coronary heart disease death—and around 335,000 will have a recurrent event. Approximately 35% of people who experience a coronary event in a given year and around 14% of patients who have an acute coronary syndrome will die from it.1 Roughly 60% of patients with an acute coronary syndrome are transported to the emergency department via ambulance.2–4.
Up to one-third of patients experiencing an MI may not complain of chest...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news
Transdermal Nitroglycerin May Help Ease Tendon Pain Transdermal Nitroglycerin May Help Ease Tendon Pain
Nitroglycerin patches help patients with common injuries to tendons, a research review suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - November 16, 2018 Category: Orthopaedics Tags: Anesthesiology News Source Type: news
Nitroglycerin patches may help ease tendon pain
(Reuters Health) - Patches containing nitroglycerin may help patients with common injuries to tendons, a research review suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Nitrolingual Pumpspray (Nitroglycerin Lingual Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 13, 2018 Category: Drugs & Pharmacology Source Type: news
Rectiv (Nitroglycerin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 29, 2017 Category: Drugs & Pharmacology Source Type: news
Glenmark gets USFDA nod for chest pain tablets
Glenmark Pharmaceuticals Inc has received final approval by the US health regulator for Nitroglycerin sublingual tablets USP in the strengths of 0.3 mg, 0.4 mg, and 0.6 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2017 Category: Pharmaceuticals Source Type: news
Do You Listen to Heart Sounds? This May be Another Reason Why You Should.
I’m not sure about you, but when I went to school to become a paramedic (and a nurse for that matter), one thing I never really understood was heart sounds, or heart tones, depending on who taught you. My attempt at learning resorted to scouring textbooks, journals, online editorials, watching clips on YouTube and listening… lots of listening to sound bites from CDs. You know the ones, they come free when you buy a new stethoscope.
Instead of turning to digital media, I should’ve been listening to the hearts of my patients. Hindsight is 20/20, especially in this case. All my self-guided education yielded few results,...
Source: JEMS Patient Care - September 12, 2017 Category: Emergency Medicine Authors: Bruce Hoffman, MSN,BSN-RN, NR-P, CFRN Tags: Patient Care Cardiac & Resuscitation Source Type: news
Advanced Pharma, Inc. D/B/A Avella of Houston Issues Voluntary Nationwide Recall of All Unexpired Nitroglycerin Injection In 5% Dextrose USP Products Produced At Its Houston Location From March 3, 2017 Through May 31, 2017 Due To Sub-Potency
Advanced Pharma, Inc. d/b/a Avella of Houston ( “Advanced Pharma”) is voluntarily recalling all unexpired lots of Nitroglycerin products that were produced at Advanced Pharma’s Houston location between March 3, 2017 and May 31, 2017 to the hospital/user level. The recall is being issued based on laboratory test results indicating a lower t han expected potency on certain lots of compounded NitroGlycerin Injection which would lead to a lower dose being administered. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 15, 2017 Category: Food Science Source Type: news
Nitroglycerin (NITRO-DUR) (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 1, 2017 Category: Drugs & Pharmacology Source Type: news
Nitro-Dur (Nitroglycerin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 3, 2017 Category: Drugs & Pharmacology Source Type: news
